BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
13.69
+2.15 (18.63%)
At close: Dec 5, 2025, 4:00 PM EST
13.75
+0.06 (0.44%)
After-hours: Dec 5, 2025, 7:48 PM EST
BBOT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -114.93 | -74.28 | -64.7 |
| Depreciation & Amortization | 0.47 | 0.21 | 0.09 |
| Loss (Gain) From Sale of Investments | -1.56 | -1.54 | - |
| Stock-Based Compensation | 3.51 | 4.43 | 16.47 |
| Other Operating Activities | 8.49 | 0.56 | - |
| Change in Accounts Payable | 2.53 | 2.5 | 0.27 |
| Change in Other Net Operating Assets | 14.79 | 13.1 | -4.2 |
| Operating Cash Flow | -86.7 | -55.03 | -52.08 |
| Capital Expenditures | -0.54 | -0.05 | -0.41 |
| Investment in Securities | 91.66 | -122.89 | - |
| Other Investing Activities | - | 2.41 | -2.41 |
| Investing Cash Flow | 91.12 | -120.53 | -2.82 |
| Issuance of Common Stock | 373.51 | 1.11 | 3.62 |
| Financing Cash Flow | 384.04 | 206.29 | 55.12 |
| Net Cash Flow | 388.46 | 30.73 | 0.23 |
| Free Cash Flow | -87.24 | -55.08 | -52.49 |
| Free Cash Flow Per Share | -7.82 | -379.51 | -420.87 |
| Levered Free Cash Flow | - | -42.53 | - |
| Unlevered Free Cash Flow | - | -42.53 | - |
| Change in Working Capital | 17.32 | 15.59 | -3.94 |
Source: S&P Capital IQ. Standard template.
Financial Sources.